Clinical Validation of Novel Neuromodulation Technologies: Methodological Considerations for Off-label and Randomized Controlled Trials

This course provides a deep dive into the advanced engineering behind next-generation spinal cord stimulation (SCS) and deep brain stimulation (DBS) technologies. The morning session spotlights academic leaders sharing foundational concepts critical to innovation in neuromodulation, covering topics such as implantable pulse generator design, electrode technology, novel stimulation paradigms, neural sensing, clinical testing strategies, and the integration of artificial intelligence. During the afternoon, you'll gain insider perspectives from engineers at top companies, as they present cutting-edge technologies recently launched or in active development. This unique structure bridges theory and application, empowering attendees with unparalleled insight into both the scientific fundamentals and real-world breakthroughs propelling neuromodulation forward. Each session features a dedicated faculty Q&A, offering direct engagement with experts. The course is tailored for a broad audience: neural engineers, clinicians, industry professionals, and researchers invested in advancing neuromodulation therapies. Attendees will explore the intricate engineering challenges of modern devices, discover emerging solutions and technologies, and understand how academic and industry innovators are shaping the future of patient care. Focused on the most relevant technological advancements and ongoing innovations, this course delivers practical knowledge that can immediately inform clinical decision-making, inspire new research directions, and support technology development in neuromodulation.